ISIN | LU1585228882 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Bellevue Emerging Markets Healthcare I EUR |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
Distributor(s) |
Bank am Bellevue AG Küsnacht Phone: +41 44 267 67 67 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
Peculiarities |
Current Price * | 121.36 EUR | 09.01.2025 |
---|---|---|
Previous Price * | 121.55 EUR | 08.01.2025 |
52 Week High * | 139.11 EUR | 04.10.2024 |
52 Week Low * | 114.14 EUR | 31.05.2024 |
NAV * | 121.36 EUR | 09.01.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 68,331,713 | |
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | -1.22% |
30.12.2024 - 09.01.2025
30.12.2024 09.01.2025 |
---|---|---|
YTD Performance (in CHF) | -1.39% |
30.12.2024 - 09.01.2025
30.12.2024 09.01.2025 |
1 month | -2.07% |
09.12.2024 - 09.01.2025
09.12.2024 09.01.2025 |
3 months | -10.60% |
09.10.2024 - 09.01.2025
09.10.2024 09.01.2025 |
6 months | +3.63% |
09.07.2024 - 09.01.2025
09.07.2024 09.01.2025 |
1 year | -7.84% |
09.01.2024 - 09.01.2025
09.01.2024 09.01.2025 |
2 years | -23.24% |
09.01.2023 - 09.01.2025
09.01.2023 09.01.2025 |
3 years | -26.52% |
10.01.2022 - 09.01.2025
10.01.2022 09.01.2025 |
5 years | -46.21% |
15.06.2021 - 09.01.2025
15.06.2021 09.01.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Sun Pharmaceuticals Industries Ltd | 6.76% | |
---|---|---|
Celltrion Inc | 6.59% | |
Apollo Hospitals Enterprise Ltd | 4.47% | |
Samsung BioLogics Co Ltd | 4.14% | |
Bangkok Dusit Medical Services PCL | 3.81% | |
Akeso Inc Ordinary Shares | 3.78% | |
Innovent Biologics Inc | 3.75% | |
Bumrungrad Hospital PCL | 3.50% | |
WuXi Biologics (Cayman) Inc | 3.41% | |
BeiGene Ltd ADR | 3.18% | |
Last data update | 31.12.2024 |
TER | 1.58% |
---|---|
TER date | 29.01.2021 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 1.54% |
SRRI ***
|
|
SRRI date *** | 31.12.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |